STOCK TITAN
  1. Home
  2. Sec-filings
  3. ANGO
  4. [Form 4] ANGIODYNAMICS INC Insider Trading Activity

AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AngioDynamics Inc. executive Laura Piccinini, SVP International, reported three exempt dispositions of common stock on July 16, 17 and 20, 2026, totaling 8,228 shares, to satisfy tax withholding obligations on pre-determined vesting of restricted stock units granted on July 16, 2025, July 17, 2024 and July 20, 2022.

Positive

  • None.

Negative

  • None.
Insider Piccinini Laura
Role SVP International
Type Security Shares Price Value
Tax Withholding Common Stock F3 616 $13.71 $8K
Tax Withholding Common Stock F2 3,074 $13.51 $42K
Tax Withholding Common Stock F1 4,538 $14.14 $64K
Holdings After Transaction: Common Stock — 58,528 shares (Direct)
Footnotes (3)
  1. F1. The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
  2. F2. The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
  3. F3. The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
Shares disposed 07/16/2026 4538.0000 shares Tax-withholding disposition at $14.1400 per share for RSUs granted July 16, 2025
Shares disposed 07/17/2026 3074.0000 shares Tax-withholding disposition at $13.5100 per share for RSUs granted July 17, 2024
Shares disposed 07/20/2026 616.0000 shares Tax-withholding disposition at $13.7100 per share for RSUs granted July 20, 2022
Total tax-withholding shares 8228 shares Aggregate shares delivered to satisfy tax withholding obligations across three vesting events
exempt disposition financial
"The exempt disposition of 4,538 shares of common stock of AngioDynamics"
tax withholding obligations financial
"was made to satisfy tax withholding obligations in connection with the pre-determined vesting"
restricted stock units financial
"vesting of shares underlying restricted stock units granted to the reporting person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did AngioDynamics (ANGO) report for Laura Piccinini?
Laura Piccinini reported three exempt dispositions of AngioDynamics common stock. The transactions covered tax withholding due on vesting of previously granted restricted stock units, rather than open-market sales, and were reported as Form 4 code F dispositions.

How many AngioDynamics (ANGO) shares were used for tax withholding?
A total of 8,228 AngioDynamics shares were delivered to satisfy tax withholding obligations. These came from three separate vesting events on July 16, 17 and 20, 2026, tied to restricted stock units granted in 2022, 2024 and 2025.

Were Laura Piccinini's AngioDynamics (ANGO) transactions open-market sales?
No. All three reported transactions were exempt dispositions to cover tax withholding on vesting restricted stock units. They reflect shares withheld or delivered for taxes, not discretionary open-market sales initiated for portfolio or investment reasons.

What were the per-share values in Laura Piccinini's AngioDynamics (ANGO) tax transactions?
The tax-withholding dispositions were valued at $14.14, $13.51 and $13.71 per share. Each value corresponds to a separate vesting event on July 16, 17 and 20, 2026, as reported in the Form 4 transaction details.

Which RSU grants triggered the AngioDynamics (ANGO) tax-withholding dispositions?
The dispositions relate to restricted stock units granted July 16, 2025, July 17, 2024 and July 20, 2022. As those RSUs vested on pre-determined schedules, shares were withheld or delivered to cover associated tax withholding obligations.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Piccinini Laura
(Last)(First)(Middle)
14 PLAZA DRIVE
(Street)
LATHAM NEW YORK 12110
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ANGIODYNAMICS INC [ ANGO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP International
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/16/2026F4,538(1)D$14.1462,218D
Common Stock07/17/2026F3,074(2)D$13.5159,144D
Common Stock07/20/2026F616(3)D$13.7158,528D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The exempt disposition of 4,538 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025.
2. The exempt disposition of 3,074 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024.
3. The exempt disposition of 616 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
/s/ Lawrence T. Weiss, Attorney in Fact07/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR